JY
DNA icon

Jeff Yass’s Ginkgo Bioworks DNA Stock Holding History

Jeff Yass’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Buy
414,700
+219,300
+112% +$1.83M ﹤0.01% 4993
2026
Q1 		$1.2M Sell
195,400
-58,900
-23% -$490K ﹤0.01% 7423
2025
Q4 		$2.11M Sell
254,300
-113,000
-31% -$1.22M ﹤0.01% 5549
2025
Q3 		$5.36M Buy
367,300
+42,400
+13% +$507K ﹤0.01% 3977
2025
Q2 		$3.66M Buy
324,900
+129,100
+66% +$1M ﹤0.01% 4568
2025
Q1 		$1.12M Sell
195,800
-81,300
-29% -$828K ﹤0.01% 6965
2024
Q4 		$2.72M Sell
277,100
-253,900
-48% -$2.18M ﹤0.01% 4654
2024
Q3 		$4.33M Buy
531,000
+522,922
+6,473% +$5.24M ﹤0.01% 3832
2024
Q2 		$107K Sell
8,078
-5,807
-42% -$173K ﹤0.01% 10988
2024
Q1 		$644K Sell
13,885
-2,875
-17% -$149K ﹤0.01% 7898
2023
Q4 		$1.13M Buy
16,760
+220
+1% +$13.5K ﹤0.01% 6683
2023
Q3 		$1.2M Buy
16,540
+2,067
+14% +$165K ﹤0.01% 6234
2023
Q2 		$1.08M Sell
14,473
-2,045
-12% -$121K ﹤0.01% 6509
2023
Q1 		$879K Buy
16,518
+345
+2% +$21.9K ﹤0.01% 7163
2022
Q4 		$1.09M Sell
16,173
-74,452
-82% -$6.85M ﹤0.01% 5987
2022
Q3 		$11.3M Buy
90,625
+28,305
+45% +$3.37M ﹤0.01% 1998
2022
Q2 		$5.93M Buy
62,320
+33,142
+114% +$4.04M ﹤0.01% 2914
2022
Q1 		$4.7M Sell
29,178
-1,017
-3% -$198K ﹤0.01% 3728
2021
Q4 		$10M Buy
30,195
+7,130
+31% +$3.39M ﹤0.01% 2712
2021
Q3 		$10.7M Buy
+23,065
New +$11.2M ﹤0.01% 2766

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Jeff Yass's DNA Position: Q2 2026 in Review

Jeff Yass reduced its Ginkgo Bioworks (DNA) stake by 30% in Q2 2026, selling an estimated $141K and leaving 39,372 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #10473.

Jeff Yass first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $12.8M in Q1 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Jeff Yass held 39,372 shares of Ginkgo Bioworks worth $390K as of Q2 2026.
  • Jeff Yass sold 16,864 Ginkgo Bioworks shares in Q2 2026, an estimated $141K.
  • Ginkgo Bioworks made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10473 holding.
  • Jeff Yass first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • Jeff Yass's Ginkgo Bioworks position peaked at $12.8M in Q1 2022.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.